Operating Expenses
Cost of sales, operating expenses, and other-net
Eli Lilly Cost of sales, operating expenses, and other-net decreased by 0.7% to $10.95B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.1%, from $9.27B to $10.95B. Over 4 years (FY 2021 to FY 2025), Cost of sales, operating expenses, and other-net shows an upward trend with a 15.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
A lower total relative to revenue indicates higher overall operational efficiency and better profit margins.
Detailed definition
This is an aggregated view of all operating costs, including cost of goods sold, R&D, SG&A, and other net operating char...
Peer comparison
Company-specific aggregation; comparable to 'Total Operating Expenses' at other firms.
Metric ID:
lly_cost_of_sales_operating_expenses_and_other_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.15B | $5.53B | $6.16B | $5.76B | $5.40B | $5.38B | $5.21B | $5.43B | $6.22B | $9.07B | $6.85B | $6.23B | $7.79B | $9.85B | $8.49B | $9.27B | $8.78B | $10.37B | $11.03B | $10.95B |
| QoQ Change | — | +7.4% | +11.4% | -6.6% | -6.2% | -0.4% | -3.2% | +4.3% | +14.6% | +45.8% | -24.5% | -9.0% | +24.9% | +26.5% | -13.8% | +9.2% | -5.3% | +18.1% | +6.3% | -0.7% |
| YoY Change | — | — | — | — | +4.9% | -2.7% | -15.5% | -5.7% | +15.3% | +68.7% | +31.5% | +14.8% | +25.1% | +8.6% | +24.1% | +48.8% | +12.8% | +5.3% | +29.8% | +18.1% |
Range$5.15B – $11.03B
CAGR+17.2%
Avg YoY Growth+17.7%
Median YoY Growth+15.0%
Cost of sales, operating expenses, and other-net at Other Companies
Frequently Asked Questions
- What is Eli Lilly's cost of sales, operating expenses, and other-net?
- Eli Lilly (LLY) reported cost of sales, operating expenses, and other-net of $10.95B in Q1 2026.
- How has Eli Lilly's cost of sales, operating expenses, and other-net changed year-over-year?
- Eli Lilly's cost of sales, operating expenses, and other-net increased by 18.1% year-over-year, from $9.27B to $10.95B.
- What is the long-term trend for Eli Lilly's cost of sales, operating expenses, and other-net?
- Over 4 years (2021 to 2025), Eli Lilly's cost of sales, operating expenses, and other-net has grown at a 15.5% compound annual growth rate (CAGR), from $22.16B to $39.45B.
- What does cost of sales, operating expenses, and other-net mean?
- The total sum of all operating expenses incurred to run the business.